Human Rabies Vaccine
The human rabies vaccine is a biological preparation that provides active immunity against the rabies virus, a fatal infection that affects the central nervous system. It works by stimulating the immune system to produce antibodies that neutralize the virus before it reaches the brain.
The vaccine is used both for pre-exposure and post-exposure prophylaxis. Pre-exposure vaccination is recommended for individuals at high risk, such as healthcare workers and veterinarians, while post-exposure vaccination is administered after a potential bite or contact with an infected animal.
Modern rabies vaccines are made from inactivated or purified viral cultures, ensuring safety and effectiveness. The vaccine is given in multiple doses depending on exposure type and vaccination status. Proper administration and adherence to the vaccination schedule are essential to prevent disease progression, as rabies is almost always fatal once symptoms appear.